Yuri Deigin, CEO of YouthBio Therapeutics and a visionary in longevity science, dives into the revolutionary potential of partial reprogramming gene therapies aimed at rejuvenating not just cells, but entire organisms. He shares insights about tackling aging as the root cause of diseases, the complexities of epigenetics, and advances in Alzheimer’s treatments. The conversation highlights ethical considerations, the challenges of funding biotech innovations, and the exciting prospects of extending lifespans through scientific discovery.
